FTC sues big pharmacy gain administrators in excess of insulin costs The company introduced action versus Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the listing price of lifetime-conserving insulin medicines. Before this summer season, the business held prolonged negotiations with Steward about https://donovanrjaqg.fitnell.com/71424397/5-tips-about-healthcare-news-you-can-use-today